PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
28-Jan-2022 Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of Psoriasis Lipidor AB
25-Jan-2022 FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy PTC Therapeutics
25-Jan-2022 CD ProGPCR Launches Gene Expression Profiling Services for GPCRs Research CD ProGPCR
25-Jan-2022 Amerigo Scientific Announces Collagen Bio Tubes for Life Science Researchers Amerigo Scientific
25-Jan-2022 CD Bioparticles Introduces New D-Glucosamines for Research Use CD Bioparticles
25-Jan-2022 CD Bioparticles Announces New Protein Magnetic Particles for Bio-application CD Bioparticles
25-Jan-2022 Creative Diagnostics Announces the Offering of Native Viral Antigens Creative Diagnostics
25-Jan-2022 Amerigo Scientific Announces Tissue Plasminogen Activator for Bio-research Amerigo Scientific
25-Jan-2022 Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis Creative Proteomics
24-Jan-2022 CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service CD Genomics
20-Jan-2022 The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults with insomnia Idorsia
19-Jan-2022 Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs) Pneumagen
19-Jan-2022 HUTCHMED Highlights Fruquintinib Clinical Data to be Presented at the 2022 ASCO Gastrointestinal Cancers Symposium HUTCHMED
12-Jan-2022 Parexel Recognized as “Top CRO to Work With” in WCG CenterWatch Global Site Relationship Benchmark Survey Parexel
09-Jan-2022 Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022 SMi Group
07-Jan-2022 The Transdermal and Microneedle Drug Delivery Virtual Conference 2022 is now only 3 weeks away! SMi Group
06-Jan-2022 WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site WuXi STA
05-Jan-2022 Emmes Acquires Institut Dr. Schauerte Emmes
24-Dec-2021 CD ProGPCR Announces GPCR Gene Synthesis Services for Researchers CD ProGPCR
24-Dec-2021 CD BioSignal Introduces Diabetes and Metabolism Solutions for Life Science Research CD BioSignal